Liang et al. reported that FGF-1 can significantly inhibit kidney inflammation (i.e., cytokines and macrophage infiltration) and renal damage in diabetic nephropathy that is related to the NF-κB and c-Jun N-terminal (c-Jun) kinase signaling pathways [40]. Here, NFKB1 is linked to diabetic kidney disease.